Intraoperative Transversus Abdominis Plane Block for Gynecologic Surgery (GYNTAP) (GYNTAP)
Postoperative Pain, Postoperative Nausea and Vomiting
About this trial
This is an interventional supportive care trial for Postoperative Pain
Eligibility Criteria
Inclusion Criteria:
- Age≥18 years old and not pregnant
- Must be able to provide informed consent - functional understanding of English
- Undergoes exploratory laparotomy with midline abdominal incision
Exclusion Criteria:
- History of substance abuse
- History of chronic pain syndrome
- Daily opioid use for more than 1 month
- Patients considered to have chorioamnionitis at the time of cesarean surgery as determined by the attending physician
- Prior abdominal surgery involving mesh or placement of an ostomy site as this may disrupt the plane in which the anesthetic may spread
- Allergy to local anesthetics
- History of cardiac arrhythmias or cardiac abnormalities
- History of seizure disorder
- Liver disease
Sites / Locations
- University of Mississippi Medical Center
Arms of the Study
Arm 1
Arm 2
Experimental
Placebo Comparator
Group A
Group B
Study participants will undergo intraoperative transversus abdominis plane (TAP) block with the syringe of medication supplied by the pharmacy using a syringe with attached spinal needle between the transversus abdominis and internal oblique. The spinal needle will be threaded horizontally and as far laterally at the superior aspect of the vertical axis of the incision as possible within this space and anesthetic will be injected after an initial pull back on the syringe to ensure there is no arterial exposure as per the following schedule: Weight <70kg: Ropivacaine 75mg - 150 mg on each side (20mL ropivacaine 3.75mg/ml each side) Weight greater than or equal to 70kg: Ropivacaine 100mg - 200mg on each side (20mL ropivacaine 5mg/ml each side
Study participants will undergo intraoperative transversus abdominis plane (TAP) block with the syringe of medication supplied by the pharmacy using a syringe with attached spinal needle between the transversus abdominis and internal oblique. The spinal needle will be threaded horizontally and as far laterally at the superior aspect of the vertical axis of the incision as possible within this space and the placebo solution will be injected after an initial pull back on the syringe to ensure there is no arterial exposure as per the following schedule: Weight <70kg: 20mL each side Weight greater than or equal to 70kg: 20mL each side